David S. Caradonna, D.M.D., M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Sinusitis | 44 | 2021 | 923 | 4.440 |
Why?
|
Rhinitis | 43 | 2021 | 691 | 4.430 |
Why?
|
Rhinitis, Allergic, Perennial | 2 | 2013 | 57 | 0.860 |
Why?
|
Rhinitis, Allergic, Seasonal | 2 | 2013 | 99 | 0.830 |
Why?
|
Chronic Disease | 46 | 2021 | 9146 | 0.760 |
Why?
|
Paranasal Sinuses | 2 | 2013 | 250 | 0.720 |
Why?
|
Adrenal Cortex Hormones | 13 | 2021 | 1855 | 0.680 |
Why?
|
Nasal Obstruction | 5 | 2019 | 151 | 0.630 |
Why?
|
Efficiency | 5 | 2018 | 462 | 0.610 |
Why?
|
Nasal Polyps | 5 | 2021 | 360 | 0.600 |
Why?
|
Quality of Life | 25 | 2020 | 12804 | 0.600 |
Why?
|
Nose Diseases | 2 | 2018 | 79 | 0.590 |
Why?
|
Asthma | 11 | 2020 | 6011 | 0.550 |
Why?
|
Absenteeism | 3 | 2018 | 250 | 0.430 |
Why?
|
Hamartoma | 1 | 2013 | 238 | 0.390 |
Why?
|
Depression | 7 | 2019 | 7766 | 0.370 |
Why?
|
Allergens | 1 | 2016 | 1320 | 0.330 |
Why?
|
Gastroesophageal Reflux | 1 | 2015 | 782 | 0.310 |
Why?
|
Anti-Asthmatic Agents | 3 | 2020 | 536 | 0.270 |
Why?
|
Sex Factors | 2 | 2019 | 10397 | 0.260 |
Why?
|
Cross-Sectional Studies | 28 | 2020 | 25043 | 0.250 |
Why?
|
Anti-Bacterial Agents | 10 | 2020 | 7181 | 0.250 |
Why?
|
Administration, Intranasal | 3 | 2019 | 446 | 0.240 |
Why?
|
Budesonide | 2 | 2021 | 154 | 0.210 |
Why?
|
Middle Aged | 44 | 2020 | 213383 | 0.190 |
Why?
|
Severity of Illness Index | 11 | 2018 | 15540 | 0.190 |
Why?
|
Comorbidity | 7 | 2019 | 10388 | 0.180 |
Why?
|
Prospective Studies | 25 | 2020 | 53288 | 0.180 |
Why?
|
Histamine Antagonists | 1 | 2019 | 93 | 0.170 |
Why?
|
Avoidance Learning | 1 | 2020 | 233 | 0.170 |
Why?
|
Otitis Media with Effusion | 1 | 2019 | 114 | 0.160 |
Why?
|
Asthma, Aspirin-Induced | 1 | 2021 | 182 | 0.160 |
Why?
|
Tooth Diseases | 1 | 2018 | 77 | 0.150 |
Why?
|
Male | 46 | 2020 | 350118 | 0.150 |
Why?
|
Disease Progression | 6 | 2018 | 13284 | 0.150 |
Why?
|
Cockroaches | 1 | 2017 | 96 | 0.150 |
Why?
|
Female | 47 | 2020 | 380194 | 0.150 |
Why?
|
Sodium Chloride | 1 | 2019 | 625 | 0.140 |
Why?
|
Adult | 32 | 2020 | 214055 | 0.140 |
Why?
|
Personality | 1 | 2020 | 552 | 0.140 |
Why?
|
Sick Leave | 1 | 2017 | 110 | 0.140 |
Why?
|
Diagnostic Self Evaluation | 1 | 2018 | 230 | 0.140 |
Why?
|
Mandibular Neoplasms | 1 | 1996 | 129 | 0.130 |
Why?
|
Ear Diseases | 1 | 2017 | 170 | 0.130 |
Why?
|
Facial Pain | 1 | 2016 | 127 | 0.130 |
Why?
|
Prednisone | 1 | 2019 | 1574 | 0.120 |
Why?
|
Steroids | 1 | 2019 | 930 | 0.120 |
Why?
|
Activities of Daily Living | 2 | 2020 | 2418 | 0.120 |
Why?
|
Humans | 57 | 2021 | 744343 | 0.120 |
Why?
|
Health Status | 2 | 2017 | 4034 | 0.110 |
Why?
|
Dental Implantation, Endosseous | 1 | 1996 | 502 | 0.110 |
Why?
|
Mandible | 1 | 1996 | 740 | 0.100 |
Why?
|
Principal Component Analysis | 1 | 2015 | 940 | 0.100 |
Why?
|
Olfaction Disorders | 1 | 2013 | 222 | 0.090 |
Why?
|
Endoscopy | 2 | 2018 | 1785 | 0.090 |
Why?
|
Administration, Oral | 4 | 2019 | 3913 | 0.090 |
Why?
|
Smoking | 2 | 2017 | 8987 | 0.090 |
Why?
|
Prostheses and Implants | 1 | 1996 | 1387 | 0.080 |
Why?
|
Follow-Up Studies | 4 | 2020 | 39050 | 0.080 |
Why?
|
Aged | 19 | 2019 | 163280 | 0.080 |
Why?
|
Hypersensitivity | 1 | 2017 | 1102 | 0.080 |
Why?
|
Emotions | 1 | 2020 | 2661 | 0.080 |
Why?
|
Biopsy, Needle | 1 | 2013 | 1641 | 0.080 |
Why?
|
Cluster Analysis | 1 | 2015 | 2715 | 0.080 |
Why?
|
Insurance Coverage | 1 | 2017 | 1901 | 0.070 |
Why?
|
Smoking Cessation | 1 | 2017 | 2071 | 0.060 |
Why?
|
Retrospective Studies | 8 | 2020 | 77449 | 0.060 |
Why?
|
Perception | 2 | 2020 | 1198 | 0.060 |
Why?
|
Radiography | 1 | 2012 | 7023 | 0.050 |
Why?
|
Emergency Service, Hospital | 1 | 2020 | 7659 | 0.050 |
Why?
|
ROC Curve | 2 | 2018 | 3527 | 0.050 |
Why?
|
Risk Factors | 6 | 2018 | 72290 | 0.050 |
Why?
|
Survival Analysis | 1 | 2013 | 10252 | 0.040 |
Why?
|
Nasal Sprays | 1 | 2019 | 18 | 0.040 |
Why?
|
Immunohistochemistry | 1 | 2013 | 11366 | 0.040 |
Why?
|
Treatment Outcome | 5 | 2019 | 63114 | 0.040 |
Why?
|
United States | 5 | 2019 | 69872 | 0.040 |
Why?
|
Postoperative Complications | 2 | 2018 | 15295 | 0.040 |
Why?
|
Periapical Abscess | 1 | 2018 | 16 | 0.040 |
Why?
|
Medication Therapy Management | 1 | 2019 | 127 | 0.040 |
Why?
|
Case-Control Studies | 1 | 2016 | 21746 | 0.040 |
Why?
|
Lingual Nerve | 1 | 1997 | 33 | 0.040 |
Why?
|
Zygomatic Fractures | 1 | 1997 | 37 | 0.040 |
Why?
|
Sneezing | 1 | 2016 | 17 | 0.040 |
Why?
|
Dentigerous Cyst | 1 | 1996 | 17 | 0.040 |
Why?
|
Hypoglossal Nerve | 1 | 1997 | 95 | 0.040 |
Why?
|
Tooth | 1 | 2018 | 207 | 0.040 |
Why?
|
Maxillary Diseases | 1 | 1996 | 51 | 0.040 |
Why?
|
Cohort Studies | 4 | 2018 | 40561 | 0.030 |
Why?
|
Factor Analysis, Statistical | 1 | 2017 | 977 | 0.030 |
Why?
|
Tongue | 1 | 1997 | 406 | 0.030 |
Why?
|
Health Status Indicators | 1 | 2019 | 969 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2019 | 14722 | 0.030 |
Why?
|
Benchmarking | 1 | 2020 | 1042 | 0.030 |
Why?
|
Prognosis | 3 | 2019 | 29063 | 0.030 |
Why?
|
Seasons | 1 | 2019 | 1493 | 0.030 |
Why?
|
Blindness | 1 | 1997 | 617 | 0.030 |
Why?
|
Bone Resorption | 1 | 1996 | 723 | 0.030 |
Why?
|
Demography | 1 | 2017 | 1656 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 2 | 2013 | 20129 | 0.020 |
Why?
|
Microsurgery | 1 | 1996 | 796 | 0.020 |
Why?
|
Cost of Illness | 1 | 2020 | 1859 | 0.020 |
Why?
|
Phenotype | 2 | 2019 | 16365 | 0.020 |
Why?
|
Aspirin | 1 | 2021 | 3282 | 0.020 |
Why?
|
Acute Disease | 1 | 2019 | 7149 | 0.020 |
Why?
|
Social Class | 1 | 2017 | 1999 | 0.020 |
Why?
|
Medication Adherence | 1 | 2019 | 2063 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2018 | 2759 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2020 | 12245 | 0.020 |
Why?
|
Self Report | 1 | 2017 | 3558 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2013 | 35421 | 0.020 |
Why?
|
Odds Ratio | 1 | 2016 | 9849 | 0.010 |
Why?
|
Pain | 1 | 2017 | 4986 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2018 | 13989 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2018 | 15076 | 0.010 |
Why?
|
Sleep | 1 | 2017 | 4623 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2017 | 19905 | 0.010 |
Why?
|
Oroantral Fistula | 1 | 1996 | 8 | 0.010 |
Why?
|
Oral Hemorrhage | 1 | 1996 | 27 | 0.010 |
Why?
|
Risk Assessment | 1 | 2018 | 23338 | 0.010 |
Why?
|
Paranasal Sinus Diseases | 1 | 1996 | 116 | 0.010 |
Why?
|
Maxillary Sinus | 1 | 1996 | 180 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 1996 | 57776 | 0.010 |
Why?
|
Accidents, Traffic | 1 | 1997 | 819 | 0.010 |
Why?
|
Young Adult | 1 | 2017 | 56430 | 0.010 |
Why?
|
Animals | 1 | 2017 | 168757 | 0.000 |
Why?
|
Recurrence | 1 | 1996 | 8340 | 0.000 |
Why?
|